Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STARJEMZA™ safely and effectively. See full prescribing information for STARJEMZA™. STARJEMZA™ (ustekinumab-hmny) injection, for subcutaneous or intravenous use Initial U.S. Approval: 202 5 STARJEMZA™ (ustekinumab-hmny) is biosimilar* to STELARA® (ustekinumab).
Medication labelWhy this: Advisory · dailymed-prescription
STARJEMZA is indicated for the treatment of adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. STARJEMZA is indicated for the treatment of adults and pediatric patients 6 years of age and older with active psoriatic arthritis. STARJEMZA is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease. STARJEMZA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
- generic_name
- ustekinumab-hmny
- product_names
- ustekinumab-hmny
- ndc
- 0143-9168, 0143-9168-01, 0143-9169, 0143-9169-01, 0143-9170, 0143-9170-01, 0143-9171, 0143-9171-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en